Cargando…
CK2-mediated CCDC106 phosphorylation is required for p53 degradation in cancer progression
BACKGROUND: Dysfunction of p53 is a key cause of cancer development, while CCDC106 can reduce p53 stability and is associated with lung cancer. However, the roles of CCDC106 in other cancer types and its upstream regulators have not been investigated. METHODS: The phosphorylation status was investig...
Autores principales: | Ning, Yichong, Wang, Chunqing, Liu, Xin, Du, Yan, Liu, Shunlian, Liu, Kaili, Zhou, Jianlin, Zhou, Chang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423756/ https://www.ncbi.nlm.nih.gov/pubmed/30885251 http://dx.doi.org/10.1186/s13046-019-1137-8 |
Ejemplares similares
-
ZCCHC10 suppresses lung cancer progression and cisplatin resistance by attenuating MDM2-mediated p53 ubiquitination and degradation
por: Ning, Yichong, et al.
Publicado: (2019) -
HPV‐CCDC106 integration promotes cervical cancer progression by facilitating the high expression of CCDC106 after HPV E6 splicing
por: Zhi, Wenhua, et al.
Publicado: (2022) -
CCDC106 promotes non-small cell lung cancer cell proliferation
por: Zhang, Xiupeng, et al.
Publicado: (2017) -
CCDC106 promotes the proliferation and invasion of ovarian cancer cells by suppressing p21 transcription through a p53-independent pathway
por: Zhao, Na, et al.
Publicado: (2022) -
MAEL contributes to gastric cancer progression by promoting ILKAP degradation
por: Zhang, Xing, et al.
Publicado: (2017)